TAKE Solutions Limited (IN:TAKE)
:TAKE
Want to see IN:TAKE full AI Analyst Report?
TAKE Stock Chart & Stats
₹40.52
₹0.00(0.00%)
At close: 4:00 PM EST
₹40.52
₹0.00(0.00%)
Day’s Range― - ―
52-Week Range₹8.16 - ₹49.90
Previous CloseN/A
Volume49.62K
Average Volume (3M)58.94K
Market Cap
₹4.58B
Enterprise Value₹4.50B
Total Cash (Recent Filing)₹1.50M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)42.7
Beta1.46
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.30
Shares Outstanding147,934,000
10 Day Avg. Volume129,011
30 Day Avg. Volume58,943
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)18.74
Price to Sales (P/S)10.72
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet HealthZero reported debt in FY2025–FY2026 materially reduces financial leverage and interest burden, improving the company's flexibility to fund operations or invest in product development. Lower leverage also reduces refinancing risk and supports longer-term strategic options.
Niche, Regulatory Business ModelTAKE’s focus on regulated life-sciences software and supply-chain execution creates durable demand because compliance, validation and integration services are sticky and high-friction. These characteristics tend to produce recurring revenue, long contract horizons, and higher switching costs for clients.
Improved Financial Risk ProfileRecovery of shareholders' equity after prior impairment, combined with zero reported debt, indicates a materially improved capital structure. That reduces solvency concerns, improves stakeholder confidence, and gives management more runway to prioritise product investment and compliance-related services.
Bears Say
Weak Cash GenerationNegative operating cash flow in consecutive years despite reported net income signals poor cash conversion and working-capital pressure. Over a multi-month horizon this can force reliance on one-off receipts, limit reinvestment in R&D or sales, and weaken the ability to scale recurring services.
Poor Profitability QualityNegative gross and operating profits alongside positive net income imply earnings are driven by below-the-line items rather than core operations. This undermines margin sustainability and suggests core product/service economics may not cover direct costs over the medium term.
Revenue VolatilityA collapse to zero revenue followed by a sharp rebound indicates unstable demand, recognition anomalies or client concentration. Such volatility reduces predictability of recurring revenue, complicates capacity planning, and raises execution and client-retention risk over coming quarters.
TAKE Solutions Limited News
TAKE FAQ
What was TAKE Solutions Limited’s price range in the past 12 months?
TAKE Solutions Limited lowest stock price was ₹8.16 and its highest was ₹49.90 in the past 12 months.
What is TAKE Solutions Limited’s market cap?
TAKE Solutions Limited’s market cap is ₹4.58B.
When is TAKE Solutions Limited’s upcoming earnings report date?
TAKE Solutions Limited’s upcoming earnings report date is Aug 12, 2026 which is in 72 days.
How were TAKE Solutions Limited’s earnings last quarter?
TAKE Solutions Limited released its earnings results on May 19, 2026. The company reported ₹0.29 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.29.
Is TAKE Solutions Limited overvalued?
According to Wall Street analysts TAKE Solutions Limited’s price is currently Overvalued.
Does TAKE Solutions Limited pay dividends?
TAKE Solutions Limited pays a Semiannually dividend of ₹0.4 which represents an annual dividend yield of N/A. See more information on TAKE Solutions Limited dividends here
What is TAKE Solutions Limited’s EPS estimate?
TAKE Solutions Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TAKE Solutions Limited have?
TAKE Solutions Limited has 147,934,000 shares outstanding.
What happened to TAKE Solutions Limited’s price movement after its last earnings report?
TAKE Solutions Limited reported an EPS of ₹0.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.961%.
Which hedge fund is a major shareholder of TAKE Solutions Limited?
Currently, no hedge funds are holding shares in IN:TAKE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TAKE Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―